36
Reducing Antipsychotics for People with Dementia in Care Homes. Evaluating a Pilot Intervention in Coventry & Warwickshire. Dr Karim Saad FRCPsych Regional Clinical Lead for Dementia, NHS West Midlands Consultant in old age psychiatry, Coventry & Warwickshire Partnership Trust Dr Bartley Sheehan MRCPsych Associate Clinical Professor in old age psychiatry, Warwick University Honorary Consultant in old age psychiatry, Coventry & Warwickshire Partnership Trust Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Reducing Antipsychotics for People with Dementia in Care Homes

  • Upload
    bcpsqc

  • View
    391

  • Download
    2

Embed Size (px)

DESCRIPTION

Reducing Antipsychotics for People with Dementia in Care Homes: Evaluating a Pilot Intervention in Coventry & Warwickshire. This file was featured in a presentation that was recorded on November 12, 2013, as part of CLeAR's monthly webinar series. It was delivered by: Dr Karim Saad FRCPsych Regional Clinical Lead for Dementia, NHS West Midlands Consultant in old age psychiatry, Coventry & Warwickshire Partnership Trust Watch a recording of this presentation: https://vimeo.com/79311561 CLeAR – a Call for Less Antipsychotics in Residential Care – aims to reduce the number of these seniors on antipsychotic medications by 50% across BC by December 31, 2014. Learn more about CLeAR: www.CLearBC.ca

Citation preview

Page 1: Reducing Antipsychotics for People with Dementia in Care Homes

Reducing Antipsychotics for People with Dementia in Care Homes.

Evaluating a Pilot Intervention in Coventry & Warwickshire.

Dr Karim Saad FRCPsychRegional Clinical Lead for Dementia, NHS West Midlands

Consultant in old age psychiatry, Coventry & Warwickshire Partnership Trust

Dr Bartley Sheehan MRCPsychAssociate Clinical Professor in old age psychiatry, Warwick University

Honorary Consultant in old age psychiatry, Coventry & Warwickshire Partnership Trust

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 2: Reducing Antipsychotics for People with Dementia in Care Homes

800,000 people with dementia (PwD) in UK

Greatest health concern for people over 55!

44% PwD receive a diagnosis

2/3 PwD live in the community while 1/3 live in a care home

400,000 Care Home residents80% of people living in care homes have a form of dementia or severe cognitive impairment

20% prescriptions for (PwD) include an Antipsychotic (AP) drug (Fossey, 2006)

1000 AP prescriptions x 12 weeks = 10 Deaths + 18 CVAs + 58-94 Gait Disturbances (Banerjee, 2009)

↑ Mortality Risk persists at least 6 months after initial prescription (DART-AD, 2009)

Quetiapine accelerates dementia decline in Care Homes residents (Ballard, 2006)Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 3: Reducing Antipsychotics for People with Dementia in Care Homes

National & Regional Priority

NHS Operating FrameworkDepartment of Health Funding for each regionReduce Prescribing to 1/3 by October 2011W Mids Regional Strategy emphasises – quality dementia services – closer to home– focus on Prevention

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 4: Reducing Antipsychotics for People with Dementia in Care Homes

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 5: Reducing Antipsychotics for People with Dementia in Care Homes

Aims

Design an Intervention for PwD in Care Homes that:

1. ↓ AP Prescriptions2. Provides a viable alternative for management

of BPSD3. Represents good value4. Can be reproducible

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 6: Reducing Antipsychotics for People with Dementia in Care Homes

The Intervention

• 1.2 WTE Nurse: – 0.6 WTE band 6 – 0.6 WTE band 5

• Duration: 3 months (2 months per Care Home)• Supervision: Authors & Pharmacist• Research Nurse sessions• Components:

A. Training InterventionB. Main Pilot Intervention

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 7: Reducing Antipsychotics for People with Dementia in Care Homes

(A) Training Intervention

• 2 sessions per Care Homes (1 week apart)• Each Session: 45 – 60 min• Target: all staff• Delivered by band 6 nurse• Session 1: identify behaviours due to dementia• Session 2: identify +ve & -ve responses to behaviours• Contents: written materials, discussion, verbal

instruction, literature review• Video: simulated residents & carers (developed for

OPERA, HTA-funded)

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 8: Reducing Antipsychotics for People with Dementia in Care Homes

(A) Training Intervention

• Session 1– Introduction (3 min)– What is dementia? (10 min)– BPSD (10 min)– Video, carer interacting with PWD with BPSD (5 – 7 min)– Discussion, what behaviours are due to dementia (15 – 17 min)

• Session 2– Recap of session 1 (5 min)– How do we respond to behaviours seen in dementia? (10 min)– Introduction of ABC & person-centred approach (10 min)– Video, carer interacting in a new way with PWD with BPSD (5 – 7 min)– Discussion of responses to behaviours in dementia (13 – 15 min)

• Feedback collected after each session

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 9: Reducing Antipsychotics for People with Dementia in Care Homes

(B) Main Pilot Intervention

• Case note review with care home managers identified PWD on AP

• Guide to appropriate AP prescribing Proforma• Cases selected for AP Withdrawal• Withdrawal plans shared with GP & Care Home• Withdrawal supervised by consultant &/or

Pharmacist• Withdrawal monitored by band 6 & 5 nurse• NPI-NH version at weeks 4 & 8

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 10: Reducing Antipsychotics for People with Dementia in Care Homes

Video

Page 11: Reducing Antipsychotics for People with Dementia in Care Homes

Results

Page 12: Reducing Antipsychotics for People with Dementia in Care Homes

The Care Homes

Care Home

Designation Location Number of residents

A Residential care, Pinnacle Care Group, dementia Rugby 18

B Care Home, privately owned, dementia Rugby 26

C Residential care, Crosscrown Ltd., dementia, old age, learning difficulties

Rugby 26

D Supported Housing, Extra care, over 55 Coventry 58 bungalows

E Care Home with Nursing, privately owned,dementia, mental health, excl. learning disability, old age

Coventry 64

F Care Home, Southern Cross, dementia Coventry 30

G Residential care, Anchor, dementia, old age Coventry 40

H Nursing Home, privately owned, old age, Rugby 40

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 13: Reducing Antipsychotics for People with Dementia in Care Homes

A total of 40 residents were taking anti-psychotic (AP) medication, in 8 Care Homes

A B C D E F G H0

1

2

3

4

5

6

7

8

9

10

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 14: Reducing Antipsychotics for People with Dementia in Care Homes

5 of 8 Care Homes withdrew residents from AP medication

A B C D E F G H0

1

2

3

4

5

6

7

8

9

10

Number taking a/p medication = 40Number withdrawn from a/p medication = 16

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 15: Reducing Antipsychotics for People with Dementia in Care Homes

Prevalence of AP Prescribing: 40/302 residents (13%)

A. Resi

dential

care,

demen

tia

B. Care

Home. Dem

entia

C. Resd

iental

care,

demen

tia

D. Supporte

d housing

E. Care

Home with

Nursing,

demen

tia

F. Care

Home, dem

entia

G. Resi

dential

care,

demen

tia

H. Nursi

ng home

0

10

20

30

40

50

60

70

Number on a/pNumber of residents

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 16: Reducing Antipsychotics for People with Dementia in Care Homes

Characteristics of 40 residents prescribed AP

• Highest rates of AP prescribing in dementia specialist Care Homes

• Lowest in Extra Care Housing Unit (no prescriptions)

• Of these 40, 16 selected for Withdrawal • All 16 were PWD

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 17: Reducing Antipsychotics for People with Dementia in Care Homes

N=16 Withdrawn off AP

Residents taking a/p - 40Residents withdrawn = 16

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 18: Reducing Antipsychotics for People with Dementia in Care Homes

AP Prescriptions

N=16 people withdrawn from antipsychotics, the following had been prescribed (range of daily doses in mg/24hr in brackets)

• Quetiapine 8 prescriptions (25-100)• Risperidone 5 prescriptions (0.5-1.5)• Haloperidol 2 prescriptions (0.5)• Olanzapine 1 prescription (10)

In the 24 people not withdrawn the following had been prescribed

• Quetiapine 10 prescriptions (12.5-100)• Risperidone 8 prescriptions (0.25-4.0)• Haloperidol 1 prescription (1.5)• Promazine 1 prescription (100)• Chlorpromazine 1 prescription (50)• Flupenthixol 1 prescription (0.6)• Olanzapine 1 prescription (5)• Amisulpiride 1 prescription (50)

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 19: Reducing Antipsychotics for People with Dementia in Care Homes

Characteristics of those withdrawn n=16

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 20: Reducing Antipsychotics for People with Dementia in Care Homes

Reasons for Non-Withdrawal n=24

Schizophrenia, n = 4Bi-polar, n = 4Behavioural, n = 6Information not provided by GP, n = 9Not known, n = 1

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 21: Reducing Antipsychotics for People with Dementia in Care Homes

Domains and scoring for NPI – NHin residents withdrawn off AP

Domain Frequency

1 2 3 4

Severity

1 2 3

Frequency + severity

Occupational disruptiveness

0 1 2 3 4 5

A. Delusions

B. Hallucinations

C. Agitation/ Aggression

D. Depression/ Dysphoria

E. Anxiety

F. Elation/ Euphoria

G. Apathy/ indifference

H. Disinhibition

I. Irritability/ Lability

J. Aberrant Motor Behaviour

TOTAL SCORE

Highest possible score = frequency + severity for each domain = 70Lowest possible score = 0Occupational disruptiveness – assessed by carer

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 22: Reducing Antipsychotics for People with Dementia in Care Homes

NPI –NH Outcomes in residents withdrawn from AP

Identifier Baseline score

4 week score

8 week score

Outcome

A1 4 – 0 missing missing

A2 8 - 4 8 – 4 missing restarted

A3 49 – 19 missing missing

A4 6 – 3 missing missing

A5 17 – 5 21 – 10 12 – 06 restarted

E1 25 – 7 22 – 9 28 – 15 restarted

E2 0 – 0 0 – 0 0 – 0

E3 14 – 5 10 – 2 9 – 3

E4 2 – 0 0 – 0 0 – 0

F1 6 – 0 9 – 0 6 – 0

F2 2 – 0 11 – 5 4 – 2 restarted

F3 0 – 0 0 – 0 0 – 0

F4 12 – 5 12 – 4 9 – 2

F5 32 – 8 12 – 2 10 – 1

G1 0 – 0 0 – 0 0 – 0

H1 0 - 0 26 - 19 4 - 2 restarted

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 23: Reducing Antipsychotics for People with Dementia in Care Homes

5/16 residents were restarted on AP within 4 weeks All were restarted because of ↑ BPSD

Residents withdrawn from a/p - 16Residents restarted = 5

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 24: Reducing Antipsychotics for People with Dementia in Care Homes

11/40 (27.5 %) successfully withdrawn for 4 weeks

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 25: Reducing Antipsychotics for People with Dementia in Care Homes

Evaluation of staff training

Training session were held in the 8 Care Homes that participated in the Pilot study.

6 Homes completed 2 sessions

2 Homes completed only 1 session

Home A, no record of second sessionHome H, cancelled second session - infection control closure to all but essential staff

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 26: Reducing Antipsychotics for People with Dementia in Care Homes

Numbers of staff attending training sessions (by years of experience as carer)

Home Session one: Session two:

Over 3 years experience

Under 3 years experience

Over 3 years experience

Under 3 years experience

A 4 1

B 5 3 4 7

C 2 1 1 1

D 5 6 4 5

E 3 1 2 1

F 4 1 4 1

G 4 0 4 0

H 5 2

Total: 32 15 19 15

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 27: Reducing Antipsychotics for People with Dementia in Care Homes

Evaluation of staff training

Evaluation of training completed by participating staff (same questions used for both sessions):

Question 1: the session was relevant to my jobQuestion 2: I learned something new from this sessionQuestion 3: I am glad I attended this sessionQuestion 4: The session was just the right length

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 28: Reducing Antipsychotics for People with Dementia in Care Homes

Evaluation of Session 1Question Total

respondedStrongly

agreeAgree Don’t

knowDisagree Strongly

disagree

1 47 42 3 0 0 2

2 46 35 9 1 0 1

3 46 38 7 0 0 1

4 47 34 8 3 1 1

Question Total responded

Strongly agree

Agree Don’t know

Disagree Strongly disagree

1 25 18 2 5 0 0

2 25 19 4 2 0 0

3 25 19 3 3 0 0

4 24 14 7 3 0 0

Evaluation of Session 2

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 29: Reducing Antipsychotics for People with Dementia in Care Homes

Staff responded positively to the training, they found it relevant and useful and expressed enthusiasm for

further teaching ‘education on medication was useful’

‘gained more understanding of behaviours in dementia

and would like more training in depth to support to give

the right skills to help people with dementia’

‘was very informative and descriptive with regards to dementia

and medication associated with it’

‘found it very informal- more of an insight to what my

residents are feeling’

‘was very interesting but also would like more training on medication; found it very informative and useful.’

‘would like more training to have better understanding to enable me to help people with dementia’

‘more training on dementia medication - also more in depth training about mood swings in relation to dementia ‘

‘more training with dealing with conflicts’

‘very informative’

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 30: Reducing Antipsychotics for People with Dementia in Care Homes

Findings 1

AP all causes N=4013% (National 20%)

AP Dementia N=16Successful

Withdrawal N=11*Failed

Withdrawal N=5

AP Other N=24

* Broadly in keeping with Banerjee, 2009

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 31: Reducing Antipsychotics for People with Dementia in Care Homes

Findings 2

• Care Home Staff Training Sessions were well attended & well received (high levels of confidence & staff satisfaction)

• Main Pilot Intervention:– Secondary prevention (Withdrawal of AP)– Replaced with individualised supervised non-

pharmacological interventions• Estimated £80,000 direct savings and £240,000

quality of life improvements per annum (Based on Burns & Chambers, 2011)

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 32: Reducing Antipsychotics for People with Dementia in Care Homes

Findings 3

• Approximately 150 Care Homes in Coventry & Warwickshire

• If 3 band 6 CPNs targeted this population FT for 1 year

• They could provide 220x2x3 half day visits = 1320 visits/year, or 8 – 9 half day visits per Care Home

• Enough to screen all residents, run 2 training sessions for care homes’ staff, monitor eligible residents at least twice, and offer some interventions

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 33: Reducing Antipsychotics for People with Dementia in Care Homes

Findings 4

• Our model would successfully secure an extra 285 PWD off AP

• In doing so: – prevent 2 – 3 extra deaths, 2 – 3 extra strokes, 15

– 25 gait disturbances per year – reducing new prescriptions – enhancing staff skills all round

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 34: Reducing Antipsychotics for People with Dementia in Care Homes

Conclusion

• Safe• Secondary Prevention Model• Clinically & cost effective• Specialist intervention• Easily reproducible• Improves experience & QoL for PWD

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 35: Reducing Antipsychotics for People with Dementia in Care Homes

Recommendations

• Suited for localities seeking to redesign the interface with Care Homes & Primary Care

• Reducing inappropriate prescriptions of Psychotropic drugs?

• Consider other configuration e.g. Band 3 healthcare support worker for follow-up role (2.5WTE band 6 & 0.5wte HCA)

Karim Saad Webinar 12 Nov 2013 CLeAR initiative British Columbia Patient Safety and Quality Council

Page 36: Reducing Antipsychotics for People with Dementia in Care Homes

Thank You!Twitter - @KarimS3DBlog - KarimS3D.com